Colistimethate Sodium 1 Million I.U. Powder for Solution for Injection
Last Updated on eMC 10-Aug-2016 View document | Beacon Pharmaceuticals Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 10-Aug-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 1 - what the product is
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 3 - dose and frequency
- Change to section 6 - date of revision
Updated on 30-Mar-2011 and displayed until 10-Aug-2016
Reasons for adding or updating:
- Change to information for healthcare professionals
- Change to warnings or special precautions for use
- Change to side-effects
- Change to dosage and administration
Updated on 18-Oct-2010 and displayed until 30-Mar-2011
Reasons for adding or updating:
- Improved Electronic Presentation
Updated on 29-Jul-2010 and displayed until 18-Oct-2010
Reasons for adding or updating:
- New PIL for new product
Beacon Pharmaceuticals
85 High Street, Tunbridge Wells, TN1 1YG
0845 437 5567
0845 437 5565
+44 (0)1233 506 574
0800 220 280
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue